Global Competitors

OTC Stocks . USA . 
Stock . Global Cord Blood
CORBF Stock   0.95  0.00  0.00%   
Global Cord Blood competes with Bioqual, Novacyt SA, Medical Developments, and Sernova Corp; as well as few others. Analyzing Global Cord competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Global Cord to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Global Cord vs Sernova Corp Correlation

Very good diversification

The correlation between Global Cord Blood and SEOVF is -0.27 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Global Cord Blood and SEOVF in the same portfolio, assuming nothing else is changed.

Moving together with Global OTC Stock

  0.65GOOG Alphabet Class CPairCorr

Moving against Global OTC Stock

  0.55MSFT Microsoft Earnings Call This WeekPairCorr
  0.49HPQ HP IncPairCorr
  0.37HD Home DepotPairCorr
Specify up to 10 symbols:
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Global Cord. Your research has to be compared to or analyzed against Global Cord's peers to derive any actionable benefits. When done correctly, Global Cord's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Global Cord Blood.

Global Cord Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Global Cord and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Global and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Global Cord Blood does not affect the price movement of the other competitor.

High positive correlations

CBSTF
+ 0.68
BIOQ
ITHUF
+ 0.64
BIOQ
CLIFF
+ 0.64
ITHUF
NVYTF
+ 0.62
CLIFF
CBSTF
+ 0.57
ITHUF
RDGL
+ 0.55
BIOQ
  

High negative correlations

MDDVF
- 0.66
NVYTF
DSOL
- 0.41
NVYTF
MDDVF
- 0.39
CLIFF
SEOVF
- 0.35
NVYTF
MDDVF
- 0.33
ITHUF
DSOL
- 0.3
CLIFF

Risk-Adjusted Indicators

There is a big difference between Global OTC Stock performing well and Global Cord OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Global Cord's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BIOQ  0.11 (0.06) 0.00  0.57  0.00 
 0.00 
 0.00 
 0.00 
 3.73 
ITHUF  9.11  0.05  0.00  0.02  0.00 
 0.00 
 20.00 
(20.00)
 53.97 
CLIFF  1.83 (0.78) 0.00 (14.91) 0.00 
 0.00 
 0.00 
 0.00 
 42.09 
NVYTF  0.18 (0.05) 0.00  0.33  0.00 
 0.00 
 0.00 
 0.00 
 7.88 
MDDVF  0.70  0.22  0.00  0.64  0.00 
 0.00 
 0.00 
 0.00 
 23.33 
CBSTF  9.73  0.34  0.00 (0.03) 11.86 
(12.95)
 25.86 
(17.50)
 137.60 
DSOL  0.81  0.34  0.00  0.45  0.00 
 0.00 
 0.00 
 0.00 
 27.27 
RDGL  3.48 (0.16) 0.00  1.10  0.00 
 0.00 
 8.89 
(8.45)
 32.50 
WOWU  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SEOVF  3.82  0.07  0.01  0.12  4.51 
(9.88)
 10.00 
(9.09)
 28.33 

Global Cord Competitive Analysis

The better you understand Global Cord competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Global Cord's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Global Cord's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CORBF BIOQ ITHUF CLIFF NVYTF MDDVF CBSTF DSOL RDGL WOWU
 0.00 
 0.95 
Global
 0.00 
 38.50 
Bioqual
 25.00 
 0.01 
IAnthus
 0.00 
 0.07 
Cordlife
 0.00 
 0.48 
Novacyt
 0.00 
 0.37 
Medical
 4.47 
 0.04 
Cannabist
 27.27 
 0 
Drug
 0.30 
 0.07 
Vivos
 0.00 
 0.0002 
WOWI
Market Volatility
(90 Days Market Risk)
Unknown risk
Very steady
Out of control
Out of control
Very risky
Out of control
Unknown risk
Out of control
Out of control
Very steady
Market Performance
(90 Days Performance)
Fair
Weakest
Weakest
Weakest
Weakest
Fair
Weakest
Fair
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Unknown
Low
Fair
Low
Low
Low
Unknown
Small
Low
Small
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
3.75
0.64
4.12
4.66
4.45
N/A
0.02
12.71
0.2
Net Asset
N/A
N/A
346.74 M
233.71 M
183.7 M
92.22 M
N/A
11.79 K
1.63 M
359.19 K
Profit Margin
N/A
0.0798
-2.49
0.0996
-0.0957
-0.55
N/A
N/A
N/A
N/A
EBITDA
N/A
8.57 M
(77.61 M)
10.78 M
(1.71 M)
(12.86 M)
N/A
(862.83 K)
(2.5 M)
(25.85 M)
Operating Margin
N/A
0.0995
-0.35
0.0687
0.0673
-0.54
N/A
-413.0
-67.68
N/A
Current Valuation
N/A
1.48 M
391.95 M
8.23 M
(50.49 M)
80.17 M
N/A
496.08 K
15.27 M
33.06 M
Price To Book
N/A
N/A
4.79
0.57
0.4
2.97
N/A
N/A
9.01
N/A
Retained Earnings
N/A
(2.75 M)
N/A
54 M
N/A
N/A
N/A
(1.68 M)
N/A
N/A
Current Asset
N/A
2.65 M
N/A
163 M
N/A
N/A
N/A
7 K
N/A
N/A
Five Year Return
N/A
1.51
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
N/A
-0.17
1.66
0.65
-2.16
1.46
N/A
-4.9
1.84
-22.5
Number Of Employees
N/A
13
17
33
210
9
N/A
3
1
5
Shares Outstanding
N/A
896 K
6.4 B
255.98 M
70.63 M
86.31 M
N/A
35.94 M
359.89 M
33.16 M
Cash Flow From Operations
N/A
313.36 K
16.15 M
9.5 M
15.69 M
(10.78 M)
N/A
(692.31 K)
(963.82 K)
(211.29 K)
Annual Yield
N/A
0.0122
N/A
0.0268
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
N/A
18.72 M
28 M
N/A
1.67 M
2.93 M
N/A
N/A
295.76 K
452 K
Return On Equity
N/A
0.14
-15.59
0.0414
-0.0198
-0.2
N/A
N/A
-1.17
N/A
Z Score
N/A
18.09
3.0
N/A
29.4
26.4
N/A
N/A
46.5
N/A
Return On Asset
N/A
0.0688
-0.11
0.0105
0.0145
-0.0787
N/A
-12.7
-0.62
N/A
Book Value Per Share
N/A
43.67
0.009
0.53
1.88
0.8
N/A
-0.003
-0.022
-0.92
Current Liabilities
N/A
985 K
N/A
33 M
N/A
N/A
N/A
391 K
N/A
N/A
Total Asset
N/A
5.05 M
346.74 M
233.71 M
183.7 M
92.22 M
N/A
11.79 K
1.63 M
359.19 K
Debt To Equity
N/A
0.5
2.48
0.021
0.012
0.047
N/A
N/A
0.21
N/A
Target Price
N/A
N/A
0.05
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
0.009
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
89.32
6.78
1.6
21.02
N/A
N/A
N/A
N/A
Market Capitalization
N/A
73.29 M
152.75 M
63.7 M
83.34 M
130.31 M
N/A
503.2 K
24.65 M
8.29 M
Price To Earning
N/A
13.03
-5.82
13.0
0.51
N/A
N/A
-1.56
0.17
N/A
Price To Sales
N/A
0.96
1.47
1.04
1.04
6.75
N/A
239.51
598.62
N/A
Net Income
N/A
5.26 M
(76.25 M)
6.13 M
(9.73 M)
(12.41 M)
N/A
(755.87 K)
(2.53 M)
(1.68 M)
Earnings Per Share
N/A
6.15
-0.39
0.02
-0.17
-0.18
N/A
-0.009
-0.009
-1.0
Shares Owned By Insiders
N/A
N/A
0.01
65.41
3.49
28.65
N/A
N/A
5.41
82.92
Revenue
N/A
67.96 M
203.02 M
56.67 M
95.78 M
22.37 M
N/A
N/A
14.89 K
N/A
Working Capital
N/A
1.67 M
N/A
130 M
N/A
N/A
N/A
(384 K)
N/A
N/A
Cash And Equivalents
N/A
2.18 M
29.8 M
64.95 M
99.65 M
28.27 M
N/A
7.12 K
1.99 M
265.96 K
Cash Per Share
N/A
2.44
N/A
0.25
1.41
0.4
N/A
N/A
0.01
0.01
Gross Profit
N/A
16.95 M
111.28 M
39.48 M
64.87 M
15.63 M
N/A
(171.22 K)
2.89 K
N/A
Day Typical Price
0.95
38.5
0.0047
0.0689
0.48
0.37
0.0433
0.0014
0.0658
2.0E-4
Accumulation Distribution
N/A
N/A
16840.0
N/A
N/A
N/A
235401.0
N/A
19670.8
N/A
Daily Balance Of Power
0.0
0.0
1.0
0.0
0.0
0.0
(0.43)
9.2 T
0.0588
0.0
Period Momentum Indicator
N/A
N/A
0.001
N/A
N/A
N/A
(0)
3.0E-4
2.0E-4
N/A
Rate Of Daily Change
1.0
1.0
1.25
1.0
1.0
1.0
0.96
1.27
1.0
1.0
Day Median Price
0.95
38.5
0.0045
0.0689
0.48
0.37
0.0425
0.0014
0.0652
2.0E-4
Price Action Indicator
N/A
N/A
0.001
N/A
N/A
N/A
0.0014
1.0E-4
0.0018
N/A
Coefficient Of Variation
1043.59
(806.71)
(380,802)
(718.96)
(1,306)
1140.97
14659.06
812.4
(3,380)
N/A
Mean Deviation
8.09
0.1112
9.11
1.83
0.1765
0.6993
9.73
0.8139
3.48
N/A
Jensen Alpha
1.56
(0.06)
0.0462
(0.78)
(0.05)
0.2208
0.3365
0.3425
(0.16)
N/A
Total Risk Alpha
0.0336
(0.11)
(1.21)
(1.30)
(0.14)
(0.03)
(1.44)
0.0898
(0.69)
N/A
Sortino Ratio
0.0718
N/A
N/A
N/A
N/A
N/A
0.0028
N/A
N/A
N/A
Downside Variance
505.8
N/A
N/A
N/A
N/A
N/A
156.41
N/A
N/A
N/A
Standard Deviation
17.68
0.4585
12.81
5.53
0.7684
2.94
16.53
3.36
5.55
N/A
Kurtosis
15.26
65.99
(0.25)
26.84
53.4
61.32
13.74
66.0
5.22
N/A
Potential Upside
26.67
N/A
20.0
N/A
N/A
N/A
25.86
N/A
8.89
N/A
Treynor Ratio
0.9456
0.5707
0.0153
(14.91)
0.3312
0.6367
(0.03)
0.4536
1.1
N/A
Maximum Drawdown
131.82
3.73
53.97
42.09
7.88
23.33
137.6
27.27
32.5
N/A
Variance
312.49
0.2102
164.02
30.63
0.5904
8.62
273.24
11.27
30.81
N/A
Market Risk Adjusted Performance
0.9556
0.5807
0.0253
(14.90)
0.3412
0.6467
(0.02)
0.4636
1.11
N/A
Risk Adjusted Performance
0.0797
(0.1)
0.0092
(0.09)
(0.06)
0.0717
0.0146
0.0979
(0.01)
N/A
Skewness
3.0
(8.12)
0.3264
(4.96)
(6.60)
7.65
2.32
8.12
(0.65)
N/A
Semi Deviation
8.25
N/A
N/A
N/A
N/A
N/A
11.86
N/A
N/A
N/A
Information Ratio
0.0914
(0.29)
(0.01)
(0.15)
(0.18)
0.061
0.0021
0.0998
(0.04)
N/A
Value At Risk
(20.00)
N/A
(20.00)
N/A
N/A
N/A
(17.50)
N/A
(8.45)
N/A
Expected Short fall
(34.96)
N/A
N/A
N/A
N/A
N/A
(12.95)
N/A
N/A
N/A
Downside Deviation
22.49
N/A
N/A
N/A
N/A
N/A
12.51
N/A
N/A
N/A
Semi Variance
68.06
N/A
N/A
N/A
N/A
N/A
140.65
N/A
N/A
N/A

Global Cord Competition Performance Charts

Five steps to successful analysis of Global Cord Competition

Global Cord's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Global Cord Blood in relation to its competition. Global Cord's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Global Cord in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Global Cord's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Global Cord Blood, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Global Cord position

In addition to having Global Cord in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Books Thematic Idea Now

Books
Books Theme
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
View All  Next Launch
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY